SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Neuberger High Yield Strategies Fund Inc. (NHS) 当前追踪市盈率 (P/E) 为 9.9. 追踪盈利收益率为 10.14%.
本页证实的标准:
- VALUE (100/100, 通过) — 市盈率低于市场平均水平 (9.9); 盈利收益率超过债券收益率 (10.14%).
- 追踪盈利收益率 10.14% — 超过典型债券收益率（约4.3%），使股票相对固定收益更具吸引力。
SharesGrow 综合评分： 80/100 其中 3/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
~
健康
67/100
Debt-to-Equity & liquidity
→ Health
估值概览 — NHS
估值倍数
P/E (TTM)9.9
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率7.46
EV/EBITDA0.0
每股数据
EPS (TTM)$0.66
每股账面价值$0.00
每股营收$0.87
每股自由现金流$0.00
收益率与内在价值
盈利收益率10.14%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$1.40 |
$29.24M |
$27.36M |
93.6% |
| 2017 |
$1.22 |
$25.82M |
$23.87M |
92.5% |
| 2018 |
$-0.16 |
$-834.75K |
$-3.09M |
- |
| 2019 |
$1.15 |
$25.51M |
$22.53M |
88.3% |
| 2020 |
$0.15 |
$6.07M |
$3.02M |
49.8% |
| 2021 |
$1.44 |
$29.51M |
$26.8M |
90.8% |
| 2022 |
$-1.72 |
$-30.38M |
$-33.49M |
- |
| 2023 |
$0.14 |
$22.35M |
$3.72M |
16.6% |
| 2024 |
$1.28 |
$41.75M |
$37.94M |
90.9% |
| 2025 |
$0.66 |
$26.72M |
$20.22M |
75.7% |
